Effects of Spirulina platensis supplementation on lipid profile in HIV–infected antiretroviral naïve patients in Yaounde - Cameroon: a randomized trial study

[1] Triant VA(2012)HIV infection and coronary heart disease: an intersection of epidemics J Infec Dis 205 355-361

[2] Glass TR(2006)Study Prevalence of risk factors for cardiovascular disease in HIVinfected patients over time: the Swiss HIV Cohort Study HIV Med 7 404-410

[3] Ungsedhapand C(2006)Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study J Acquir Immune Defic Syndr 43 27-34

[4] Wolbers M(2007)Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease J Clin Endo Crinol Metab 92 2506-2512

[5] Weber R(2008)Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalite 2000 and 2005” surveys (ANRS EN19 and Mortavic) J Acquir Immune Defic Syndr 48 590-598

[6] Vernazza PL(2013)HIV and coronary heart disease time for a better understanding J Am Coll Card 61 511-523

[7] Rickenbach M(2005)Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naïve cohort HIV Med 6 114-121

[8] Furrer H(2013)Risk factors for subclinical atherosclerosis in HIV-infected patients under and over 40 years: a case–control study BMC Infec Dis 13 214-185

[9] Bernasconi E(1998)The Prevalence of Hypertension in Rural and Urban Cameroon Int J Epidemiol 27 181-243

[10] Cavassini M(2013)Profile of cardiac disease in Cameroon and impact on health care services Cardiovasc Diagn Ther 3 236-237

[1] Triant VA(2012)HIV infection and coronary heart disease: an intersection of epidemics J Infec Dis 205 355-361

[2] Glass TR(2006)Study Prevalence of risk factors for cardiovascular disease in HIVinfected patients over time: the Swiss HIV Cohort Study HIV Med 7 404-410

[3] Ungsedhapand C(2006)Mortality in the highly active antiretroviral therapy era: changing causes of death and disease in the HIV outpatient study J Acquir Immune Defic Syndr 43 27-34

[4] Wolbers M(2007)Increased acute myocardial infarction rates and cardiovascular risk factors among patients with human immunodeficiency virus disease J Clin Endo Crinol Metab 92 2506-2512

[5] Weber R(2008)Changes in causes of death among adults infected by HIV between 2000 and 2005: The “Mortalite 2000 and 2005” surveys (ANRS EN19 and Mortavic) J Acquir Immune Defic Syndr 48 590-598

[6] Vernazza PL(2013)HIV and coronary heart disease time for a better understanding J Am Coll Card 61 511-523

[7] Rickenbach M(2005)Effects of HIV disease on lipid, glucose and insulin levels: results from a large antiretroviral-naïve cohort HIV Med 6 114-121

[8] Furrer H(2013)Risk factors for subclinical atherosclerosis in HIV-infected patients under and over 40 years: a case–control study BMC Infec Dis 13 214-185

[9] Bernasconi E(1998)The Prevalence of Hypertension in Rural and Urban Cameroon Int J Epidemiol 27 181-243

[10] Cavassini M(2013)Profile of cardiac disease in Cameroon and impact on health care services Cardiovasc Diagn Ther 3 236-237